Olema Pharmaceuticals Inc...

4.21
-0.16 (-3.66%)
At close: Mar 03, 2025, 3:59 PM
4.25
0.83%
After-hours: Mar 03, 2025, 06:01 PM EST

Olema Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 68.54M 23.7M 287.25M 338.55M 68K 3.15M
Short-Term Investments 193.27M 180.72M 273.44M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 7.17M 2.77M 3.98M 510K 3K 3K
Receivables 673K 319K n/a n/a n/a n/a
Inventory n/a -319K -353K n/a n/a n/a
Other Current Assets 4.03M 4.16M 3.31M 3.59M 35K 93K
Total Current Assets 266.51M 208.9M 287.25M 342.14M 103K 3.24M
Property-Plant & Equipment 3.26M 3.98M 4.72M 75K 26K 26K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 10.43M 6.75M 8.7M 585K 29K 29K
Total Assets 276.94M 215.65M 295.94M 342.72M 132K 3.27M
Account Payables 2.7M 374K 23K 719K 935K 116K
Deferred Revenue n/a n/a 7.69M n/a n/a n/a
Short-Term Debt 988K 1.01M 1.86M n/a n/a n/a
Other Current Liabilities 17.86M 15.09M 7.05M 3.22M 443K 85K
Total Current Liabilities 21.62M 16.55M 9.02M 4.58M 1.38M 201K
Long-Term Debt 1.43M 1.55M 2.36M n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a 9.35M
Total Long-Term Liabilities 1.43M 1.55M 2.36M n/a 9.35M 9.35M
Total Liabilities 23.05M 18.1M 11.38M 4.58M 10.73M 9.55M
Total Debt 2.42M 2.56M 3.29M n/a n/a n/a
Common Stock 4K 3K 3K 3K 1K 1K
Retained Earnings -305.63M -208.98M -104.19M -33.09M -10.76M -6.45M
Comprehensive Income 347K -1.81M -149K -342.72M -9.35M -71K
Shareholders Equity 253.9M 197.55M 284.57M 338.14M -10.59M -6.28M
Total Investments 193.27M 180.72M 273.44M n/a n/a n/a